Overview

A Study to Assess Menstrual Cramp Pain Associated With Primary Dysmenorrhea

Status:
Completed
Trial end date:
2018-09-05
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the maximum single dose of AleveĀ® (two tablets, equivalent to 440 mg of naproxen sodium) to the maximum single dose of Tylenol Extra Strength (two caplets, equivalent to 1000 mg of acetaminophen) in the treatment of menstrual pain associated with primary dysmenorrhea.
Phase:
Phase 4
Details
Lead Sponsor:
Bayer
Treatments:
Acetaminophen
Naproxen